A practical and scalable system for heteroaryl amino acid synthesis.
Chemical
Science
View Article Online
Open Access Article. Published on 02 October 2017. Downloaded on 15/03/2018 14:26:43.
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.
EDGE ARTICLE
Cite this: Chem. Sci., 2017, 8, 7998
View Journal | View Issue
A practical and scalable system for heteroaryl
amino acid synthesis†
R. A. Aycock, D. B. Vogt and N. T. Jui
*
A robust system for the preparation of b-heteroaryl a-amino acid derivatives has been developed using
photoredox catalysis. This system operates via regiospecific activation of halogenated pyridines (or other
Received 17th August 2017
Accepted 2nd October 2017
heterocycles) and conjugate addition to dehydroalanine derivatives to deliver a wide range of unnatural
amino acids. This process was conducted with good efficiency on large scale, the application of these
DOI: 10.1039/c7sc03612d
conditions to amino ketone synthesis is shown, and a simple protocol is given for the preparation of
rsc.li/chemical-science
enantioenriched amino acid synthesis, from a number of radical precursors.
Introduction
Amino acids play a central role in the chemical and biological
sciences. As primary members of the chiral pool, they are
precursors to drugs,1 chiral auxiliaries,2 and catalysts.3 In
addition, they are fundamental building blocks for the
construction of biomolecules. The use of peptides as therapeutic agents is attractive because they can display extremely
diverse, potent, and selective biological activities.4 However,
there are signicant challenges in peptide drug design,
including low metabolic stability or poor physical properties.
One proven strategy for overcoming these challenges involves
substitution of the native residues with unnatural amino acids
(synthetic mutagenesis).5 Nitrogen-containing heteroaromatics
are common in pharmaceuticals because they directly alter the
solubility, metabolic stability, and binding affinity of the
molecules that they comprise.6 As such, heteroarene-containing
unnatural amino acids are promising tools in the design of
peptide therapeutics.
Pyridine incorporation has a dramatic impact on the properties of amino acids and peptides. For example, azatyrosine—
a natural product that differs from the essential amino acid
tyrosine by substitution of a single atom—displays potent
antibiotic and antitumor properties (Fig. 1A).7 Installation of
the 3-pyridylalanine (3-pyr-Ala) residue in the gonadotropinreleasing hormone antagonist cetrorelix (Fig. 1B) was found to
improve both aqueous solubility and receptor affinity,8 and
similar effects were observed in the development of other
peptide hormones (not shown).5b–d As part of a program
centered on the catalytic functionalization of heteroaromatics,
we target the development of impactful synthetic methods for
Department of Chemistry and Winship Cancer Institute, Emory University, Atlanta, GA
30322, USA. E-mail:
† Electronic supplementary
10.1039/c7sc03612d
information
7998 | Chem. Sci., 2017, 8, 7998–8003
(ESI)
available.
See
DOI:
the construction of novel b-heteroaryl a-amino acids through
a radical conjugate addition mechanism.
We have found that pyridyl halide activation via single
electron reduction using photoredox catalysts9 can be accomplished, and that the intermolecular reactivity of the resulting
radical species can be dictated by the reaction conditions.10,11
More specically, we found that pyridyl radicals display nucleophilic reactivity in aqueous DMSO, and they readily couple
with electron-poor alkenes. We questioned whether this
approach could be translated to heteroaryl amino acid synthesis
through radical conjugate addition to dehydroalanine derivatives. There are a number of powerful methods for the synthesis
Fig. 1
Impact of pyridine incorporation into amino acids and peptide
drugs.
This journal is © The Royal Society of Chemistry 2017
View Article Online
Open Access Article. Published on 02 October 2017. Downloaded on 15/03/2018 14:26:43.
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.
Edge Article
of unnatural b-heteroaryl a-amino acids, including malonate (or
enolate) alkylation,12 cross-coupling of serine-derived organometallic reagents,13 and reduction of dehydroamino acid
derivatives.14 However, strategies based on radical addition to
DHA derivatives are unique due to the highly-chemoselective
nature of radical species, and the broad functional group
tolerance that results.15 Alkyl radical addition to DHA has been
effectively accomplished even in the complex setting of intact
proteins.16 While this is a highly attractive attribute, a radical
approach to heteroaryl amino acids is currently unknown. Here,
we describe the successful translation of our reductive heteroarene activation system to amino acid synthesis.
Results and discussion
Shown in Fig. 2 is a mechanistic picture that is consistent with
our observations. Excitation of the photocatalyst [Ir(ppy)2
(dtbbpy)]PF6 ([Ir]1+), followed by reductive quenching of
the excited state by Hantzsch ester (HEH) gives rise to the [Ir]0
(E1/2 ¼ 1.51 V).17 Stern–Volmer quenching studies indicated
that Hantzsch ester is the most signicant excited state
quencher (see ESI for details†). Single electron reduction of halo
pyridine I, followed by rapid mesolytic cleavage in polar solvents
(X ¼ Br, I)18 affords heteroaryl radical intermediate II, which
exhibits nucleophilic radical behavior in aqueous DMSO.10a It is
possible that halopyridine reduction is assisted by protonation,
as each catalytic turnover produces an nominal equivalent of
Hantzsch pyridinium bromide (HEH+ Br). Hydrodehalogenation (HDH) of the arene is observed as a common
Chemical Science
byproduct, but this undesired pathway can be suppressed by
limiting the solubility of the stoichiometric reductant, Hantzsch
ester (HEH), in accord with our previous ndings. Radical
conjugate addition (RCA) to dehydroalanine III and subsequent
single electron reduction of the nascent radical IV would deliver
the corresponding enolate V. The intermediacy of V is supported by the fact that the a-H amino acid product VI is
produced in the presence of H2O as a cosolvent (regardless of
H/D labeling of HEH). Conversely, when D2O is used as
a cosolvent, complete deuterium incorporation is obtained at
the a-position.
As illustrated in Table 1, we identied conditions that efficiently unite 2-bromo-5-hydroxypyridine with the indicated
dehydroalanine derivative (readily accessed on 35 g scale from
Boc-Ser-OMe) to give the protected azatyrosine 1 in 98% NMR
yield (entry 1). These conditions employ 1 mol% of the photosensitizer [Ir(ppy)2(dtbbpy)]PF6 (excited by irradiation with
a commercial blue LED) and Hantzsch ester (1.5 equiv.) as a stoichiometric reductant in aqueous DMSO. Control experiments
indicated that all of these components are necessary for the
reaction (entries 2–4, 0% yield), and that use of the prototypical
Ru(bpy)32+ chromophore results (...truncated)